[HTML][HTML] Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes

A Petruzziello, S Marigliano, G Loquercio… - World journal of …, 2016 - ncbi.nlm.nih.gov
METHODS We conducted a systematic study which represents one of the most
comprehensive effort to quantify global HCV epidemiology, using the best available …

[HTML][HTML] Global epidemiology and genotype distribution of the hepatitis C virus infection

E Gower, C Estes, S Blach, K Razavi-Shearer… - Journal of …, 2014 - Elsevier
The treatment of chronic hepatitis C virus (HCV) infection has the potential to change
significantly over the next few years as therapeutic regimens are rapidly evolving. However …

[책][B] Global hepatitis report 2017

World Health Organization - 2017 - apps.who.int
Under the terms of this licence, you may copy, redistribute and adapt the work for
noncommercial purposes, provided the work is appropriately cited, as indicated below. In …

Global burden of cancers attributable to infections in 2012: a synthetic analysis

M Plummer, C de Martel, J Vignat, J Ferlay… - The Lancet Global …, 2016 - thelancet.com
Background Infections with certain viruses, bacteria, and parasites are strong risk factors for
specific cancers. As new cancer statistics and epidemiological findings have accumulated in …

Global epidemiology and burden of HCV infection and HCV-related disease

AP Thrift, HB El-Serag, F Kanwal - Nature reviews Gastroenterology & …, 2017 - nature.com
Chronic HCV infection is a global health problem that affects> 184 million people worldwide.
HCV is associated with several hepatic and extrahepatic disorders, including several …

Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis

B Simmons, J Saleem, A Hill, RD Riley… - Clinical Infectious …, 2016 - academic.oup.com
Background. Treatment for hepatitis C virus (HCV) can lead to sustained virological
response (SVR) in over 90% of people. Subsequent recurrence of HCV, either from late …

[HTML][HTML] From non-A, non-B hepatitis to hepatitis C virus cure

JM Pawlotsky, JJ Feld, S Zeuzem, JH Hoofnagle - Journal of hepatology, 2015 - Elsevier
The hepatitis C virus (HCV) was discovered in the late 1980s. Interferon (IFN)-α was
proposed as an antiviral treatment for chronic hepatitis C at about the same time. Successive …

Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: a systematic review

S Bajis, GJ Dore, B Hajarizadeh… - International Journal of …, 2017 - Elsevier
Background The burden of hepatitis C virus (HCV) infection is escalating among people who
inject drugs (PWID), yet testing and treatment remains suboptimal. The aim of this systematic …

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

H Razavi, I Waked, C Sarrazin, RP Myers… - Journal of viral …, 2014 - Wiley Online Library
The disease burden of hepatitis C virus (HCV) is expected to increase as the infected
population ages. A modelling approach was used to estimate the total number of viremic …

HCV epidemiology in high-risk groups and the risk of reinfection

H Midgard, A Weir, N Palmateer, VL Re III… - Journal of …, 2016 - Elsevier
Injecting risk behaviours among people who inject drugs (PWID) and high-risk sexual
practices among men who have sex with men (MSM) are important routes of hepatitis C …